Literature DB >> 25413553

A review of the adverse side effects associated with antipsychotics as related to their efficacy.

Jina Pakpoor1, Mark Agius.   

Abstract

Since the introduction of antipsychotic medication for the treatment of psychosis, a wide range of different types of antipsychotic drugs have been developed while their side effects have become evident. The side effects of both the typical and atypical generation of antipsychotics have important consequences for the quality of life of recipients, stigma experienced and also the level of care of patients. It is well acknowledged that the side effects of antipsychotics reduce compliance with the medication. In this review the data for an association between typical and atypical antipsychotics and the main side effects that are well-supported in the literature was explored: weight gain and associated metabolic effects; extrapyramidal symptoms and tardive dyskinesia; prolactin elevation and associated sexual effects; QTc elongation; and a group of miscellaneous side effects. It has been demonstrated that the production of adverse effects following the use of antipsychotic medication differs widely both between atypical and typical drugs but also within these subgroups. Considering the wide range of antipsychotics available amongst both groups and the differing effects they have on patients in terms of side effects, there is reason to believe that a more personalised approach to antipsychotic treatment should be considered. Additionally, screening for risk factors, screening for the appearance of side effects, as well as good communication with patients about the side effects and other options available are important tasks for clinicians in order to optimise concordance with medication.

Entities:  

Year:  2014        PMID: 25413553

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  8 in total

1.  Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia.

Authors:  Istvan Bitter; Jeffrey A Lieberman; Florence Gaudoux; Pierre Sokoloff; Mélanie Groc; Rajeev Chavda; Cécile Delsol; Laurence Barthe; Valérie Brunner; Carine Fabre; Marine Fagard; Agnès Montagne; Françoise Tonner
Journal:  Neuropsychopharmacology       Date:  2019-03-01       Impact factor: 7.853

Review 2.  Chlorpromazine versus clotiapine for schizophrenia.

Authors:  Shahrzad Mazhari; Saeed Esmailian; Armita Shah-Esmaeili; Ali S Goughari; Azam Bazrafshan; Morteza Zare
Journal:  Cochrane Database Syst Rev       Date:  2017-04-07

3.  Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study.

Authors:  Merhawi Bahta; Tzeggai Berhe; Mulugeta Russom; Eyasu H Tesfamariam; Azieb Ogbaghebriel
Journal:  Integr Pharm Res Pract       Date:  2020-10-14

Review 4.  Brain in flames - animal models of psychosis: utility and limitations.

Authors:  Daniele Mattei; Regina Schweibold; Susanne A Wolf
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

5.  Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications.

Authors:  Pierre-Michel Llorca; Christophe Lançon; Ann Hartry; T Michelle Brown; Dana B DiBenedetti; Siddhesh A Kamat; Clément François
Journal:  BMC Psychiatry       Date:  2017-02-13       Impact factor: 3.630

6.  Antipsychotic use in a resource-limited setting: Findings in an Eastern Cape psychiatric hospital.

Authors:  Ingrid Eloff; Willem Esterhuysen; Kavendren Odayar
Journal:  S Afr J Psychiatr       Date:  2017-07-18       Impact factor: 1.550

7.  Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital.

Authors:  Fikadu Ejeta; Temesgen Aferu; Diriba Feyisa; Oliyad Kebede; Jafer Siraj; Workineh Woldeselassie Hammeso; Esayas Tadesse; Alemayehu Tinishku
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-29       Impact factor: 2.570

Review 8.  Psychological interventions for bipolar disorder in low- and middle-income countries: systematic review.

Authors:  Mekdes Demissie; Charlotte Hanlon; Rahel Birhane; Lauren Ng; Girmay Medhin; Abebaw Fekadu
Journal:  BJPsych Open       Date:  2018-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.